Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Login and Edit functionaility are currrently unavailable.
Return to Top
Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. Pediatr Cardiol. 2008 Mar; 29(2):343-51.
View in:
PubMed
subject areas
Adolescent
Adrenergic beta-Antagonists
Adult
Carbazoles
Cardiomyopathy, Dilated
Dose-Response Relationship, Drug
Echocardiography, Doppler, Pulsed
Electrocardiography, Ambulatory
Follow-Up Studies
Heart Ventricles
Humans
Magnetic Resonance Imaging
Middle Aged
Muscular Dystrophies
Myocardial Contraction
Propanolamines
Prospective Studies
Severity of Illness Index
Stroke Volume
Treatment Outcome
Ventricular Function, Left
authors with profiles
Tal Geva, M.D.
Kathy Jennifer Jenkins, M.D.
Jonathan Rhodes, M.D.
Steven D. Colan, M.D.
Basil T. Darras, M.D.
Renee Margossian, M.D.
Andrew James Powell, M.D.